New study spotlights a link between blockbuster SGLT2 drugs and potentially lethal gangrene
A new study in the Annals of Internal Medicine highlights an apparent connection between the new wave of SGLT2 diabetes drugs and extremely rare cases of flesh-eating bacteria called Fournier gangrene that attacks the genital and rectal areas of patients.
Researchers tracked 55 cases of necrotizing fasciitis over 6 years leading up to January 31, 2019. All of these incidents were flagged by the FDA’s Adverse Event Reporting System. Thirty-nine of the victims were men, the rest women. Several of the patients required surgery while three died and two others required amputations to stop the attack.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
